Literature DB >> 31776808

Iodine nutrition in pregnant and breastfeeding women: sufficiency, deficiency, and supplementation.

Hossein Delshad1, Fereidoun Azizi2.   

Abstract

Iodine is a micronutrient used by the thyroid gland to produce thyroid hormones, which manage different aspects of body metabolism. Humans depend on exogenous sources of iodine to maintain the normal concentration of thyroid hormones. Pregnancy alters iodine turnover and is associated with significant changes in thyroid function. Daily iodine requirement during pregnancy increases to 250 μg, compared with 150 μg for nonpregnant women. According to recent guidelines of scientific organizations, to improve maternal thyroid status and to prevent child neurocognitive defects, all pregnant and breastfeeding women should take 150 μg of iodine supplementation, not only in iodine-deficient regions but also in iodine-sufficient areas. However, some recent studies have confirmed that iodine supplementation of mildly iodine-deficient pregnant women has no clear benefits as concerns maternal thyroid function or child neurodevelopment.

Entities:  

Keywords:  Iodine deficiency; Iodine status; Iodine supplementation; Lactation; Pregnancy

Mesh:

Substances:

Year:  2019        PMID: 31776808     DOI: 10.1007/s42000-019-00160-2

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  2 in total

Review 1.  8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) and 8-hydroxy-2'-deoxyguanosine (8-OHdG) as a Cause of Autoimmune Thyroid Diseases (AITD) During Pregnancy?

Authors:  Krzysztof M Halczuk; Karolina Boguszewska; Sandra K Urbaniak; Michał Szewczuk; Bolesław T Karwowski
Journal:  Yale J Biol Med       Date:  2020-09-30

Review 2.  Thyroid Gene Mutations in Pregnant and Breastfeeding Women Diagnosed With Transient Congenital Hypothyroidism: Implications for the Offspring's Health.

Authors:  Maria C Opazo; Juan Carlos Rivera; Pablo A Gonzalez; Susan M Bueno; Alexis M Kalergis; Claudia A Riedel
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-14       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.